Forthcoming changes
Planned changes for UniProt
Planned changes for UniProt
Plasma membrane rupture during cell death: from a passive hypothesis to an active process | Changes to the controlled vocabulary of human diseases
Oocyte waste disposal strategy: 'store to degrade later' | Removal of the cross-references to CLAE | Removal of the cross-references to COMPLUYEAST-2DPAGE
The culprit for extreme morning sickness identified | Removal of the cross-references to Genevisible | Removal of the cross-references to SWISS-2DPAGE
CMV infections: plants beaten at their own game | Changes to the controlled vocabulary of human diseases | Changes to the controlled vocabulary for PTMs
Vitamin K beyond coagulation | Cross-references to EMDB | Cross-references to JaponicusDB | Changes to the controlled vocabulary...
In recent years a wealth of information has become available about genetic variations that underlie various diseases, especially cancer.
A conversation with machine learning engineer Andreea Gane. At UniProt we are very interested in engaging with the machine learning community
When humans migrated from Africa to other parts of the globe, they carried with them a certain set of genes. Over the many thousands of years that have passed since, a good deal of these genes have been subjected to minor or perhaps major changes as our…
Find answers through our help center or get in touch
Join speakers from UniProt as they explore this data resource of protein sequence and functional information. The series will start with presentation of the UniProt website, followed by an interactive exploration of the API for programmatic access. Further webinars will be added until May 2025, including functional annotation, use of BLAST, automatic annotation, and variants and disease. The webinars making up this series are listed below. Follow the links to find out more about each webinar. You will need to register for each webinar you would like to attend. Recordings will be made openly available of all webinars on their individual pages.